ABS Biotechnologies provides high-quality iPSC-derived human smooth muscle cells (SMCs) generated from ethnically diverse, carefully screened, and consented donors using optimised differentiation and expansion protocols. Our SMCs are produced to support disease modelling, drug discovery, toxicology studies, and regenerative medicine research.
All SMC products undergo rigorous quality control to ensure consistency, identity, and functionality. Standard quality assessments include verification of smooth muscle-specific marker expression, functional contractility assays, and evaluation of responsiveness to relevant pharmacological and physiological stimuli.
New treatments have to be safe.
